Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silk

Showing results (1231-1240 of 1,449) with videos related to

Pageof 145
Sort By:
Royal Society Open Science|May 21, 2020
Genetic evidence further elucidates the history and extent of badger introductions from Great Britain into IrelandAdrian Allen, Jimena Guerrero, Andrew Byrne, et al.
European Journal of Medical Research|July 2, 2022
A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumorsAnn W Silk, Biren Saraiya, Roman Groisberg, et al.
Tuberculosis (Edinburgh, Scotland)|August 15, 2022
Molecular surveillance for large outbreaks of tuberculosis in the United States, 2014-2018Kala M Raz, Sarah Talarico, Sandy P Althomsons, et al.
Microbial Genomics|September 1, 2021
<i>w</i>Mel <i>Wolbachia</i> genome remains stable after 7 years in Australian <i>Aedes aegypti</i> field populationsKimberley R Dainty, Jane Hawkey, Louise M Judd, et al.
Frontiers in Oncology|January 31, 2020
High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced MelanomaAnn W Silk, Howard L Kaufman, Brendan Curti, et al.
Cell Reports|April 18, 2019
Pulsatile MEK Inhibition Improves Anti-tumor Immunity and T Cell Function in Murine Kras Mutant Lung CancerHyejin Choi, Jiehui Deng, Shuai Li, et al.
Pigment Cell & Melanoma Research|February 18, 2018
A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanomaJanice M Mehnert, Ann W Silk, J H Lee, et al.
The International Journal on Drug Policy|November 17, 2022
Hepatitis C cure and medications for opioid use disorder improve health-related quality of life in patients with opioid use disorder actively engaged in substance useMax Spaderna, Sarah Kattakuzhy, Sun Jung Kang, et al.
Cancers|December 23, 2022
Real-Time Split-Dose PET/CT-Guided Ablation Improves Colorectal Liver Metastasis Detection and Ablation Zone Margin Assessments without the Need for Repeated Contrast InjectionMahdi Zirakchian Zadeh, Randy Yeh, Henry S Kunin, et al.
Bioinformatics (Oxford, England)|May 14, 2020
EasyVS: a user-friendly web-based tool for molecule library selection and structure-based virtual screeningDouglas E V Pires, Wandré N P Veloso, YooChan Myung, et al.
Pageof 145

Showing results (1231-1240 of 1,449) with videos related to

Sort By:
Pageof 145
Royal Society Open Science|May 21, 2020
Genetic evidence further elucidates the history and extent of badger introductions from Great Britain into IrelandAdrian Allen, Jimena Guerrero, Andrew Byrne, et al.
European Journal of Medical Research|July 2, 2022
A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumorsAnn W Silk, Biren Saraiya, Roman Groisberg, et al.
Tuberculosis (Edinburgh, Scotland)|August 15, 2022
Molecular surveillance for large outbreaks of tuberculosis in the United States, 2014-2018Kala M Raz, Sarah Talarico, Sandy P Althomsons, et al.
Microbial Genomics|September 1, 2021
<i>w</i>Mel <i>Wolbachia</i> genome remains stable after 7 years in Australian <i>Aedes aegypti</i> field populationsKimberley R Dainty, Jane Hawkey, Louise M Judd, et al.
Frontiers in Oncology|January 31, 2020
High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced MelanomaAnn W Silk, Howard L Kaufman, Brendan Curti, et al.
Cell Reports|April 18, 2019
Pulsatile MEK Inhibition Improves Anti-tumor Immunity and T Cell Function in Murine Kras Mutant Lung CancerHyejin Choi, Jiehui Deng, Shuai Li, et al.
Pigment Cell & Melanoma Research|February 18, 2018
A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanomaJanice M Mehnert, Ann W Silk, J H Lee, et al.
The International Journal on Drug Policy|November 17, 2022
Hepatitis C cure and medications for opioid use disorder improve health-related quality of life in patients with opioid use disorder actively engaged in substance useMax Spaderna, Sarah Kattakuzhy, Sun Jung Kang, et al.
Cancers|December 23, 2022
Real-Time Split-Dose PET/CT-Guided Ablation Improves Colorectal Liver Metastasis Detection and Ablation Zone Margin Assessments without the Need for Repeated Contrast InjectionMahdi Zirakchian Zadeh, Randy Yeh, Henry S Kunin, et al.
Bioinformatics (Oxford, England)|May 14, 2020
EasyVS: a user-friendly web-based tool for molecule library selection and structure-based virtual screeningDouglas E V Pires, Wandré N P Veloso, YooChan Myung, et al.
Pageof 145